blood tests for breast cancer

Release time ：Nov-15,2024

Blood tests for breast cancer typically offer valuable insights into the disease's status, yet they are not sufficient as standalone diagnostic tools. These assessments are instrumental in monitoring treatment responses, evaluating the likelihood of recurrence, and detecting early indications of the disease.

Common markers in breast cancer blood tests include tumor markers such as CA 15-3 and CEA; elevated levels of these may suggest the presence or recurrence of cancer. Furthermore, blood biochemical analyses can evaluate liver and kidney functions, which can be compromised during cancer therapy. Blood cell counts, including a complete blood count (CBC), can indicate anemia, infections, or other complications. Coagulation tests like prothrombin time (PT) and activated partial thromboplastin time (APTT) are particularly crucial for patients undergoing treatments that might heighten the risk of bleeding. Lastly, genetic testing, such as BRCA gene mutation analysis, can identify individuals at high risk due to a family history of breast cancer.

If you suspect you may have breast cancer or are experiencing related symptoms, promptly seek medical attention and consult with a healthcare professional. Always adhere to your physician's recommendations before initiating any treatment and refrain from employing unproven therapeutic methods without professional guidance.